NO161558C - Analogifremgangsmaate til fremstilling av antihypertensivebenzazepin-2-oner. - Google Patents

Analogifremgangsmaate til fremstilling av antihypertensivebenzazepin-2-oner.

Info

Publication number
NO161558C
NO161558C NO822722A NO822722A NO161558C NO 161558 C NO161558 C NO 161558C NO 822722 A NO822722 A NO 822722A NO 822722 A NO822722 A NO 822722A NO 161558 C NO161558 C NO 161558C
Authority
NO
Norway
Prior art keywords
oner
benzazepin
antihypertensive
preparation
analogy procedure
Prior art date
Application number
NO822722A
Other languages
English (en)
Other versions
NO822722L (no
NO161558B (no
Inventor
Jeffrey W H Watthey
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO822722L publication Critical patent/NO822722L/no
Publication of NO161558B publication Critical patent/NO161558B/no
Publication of NO161558C publication Critical patent/NO161558C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO822722A 1981-08-11 1982-08-10 Analogifremgangsmaate til fremstilling av antihypertensivebenzazepin-2-oner. NO161558C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29190781A 1981-08-11 1981-08-11
US31986381A 1981-11-09 1981-11-09

Publications (3)

Publication Number Publication Date
NO822722L NO822722L (no) 1983-02-14
NO161558B NO161558B (no) 1989-05-22
NO161558C true NO161558C (no) 1989-08-30

Family

ID=26967047

Family Applications (1)

Application Number Title Priority Date Filing Date
NO822722A NO161558C (no) 1981-08-11 1982-08-10 Analogifremgangsmaate til fremstilling av antihypertensivebenzazepin-2-oner.

Country Status (22)

Country Link
EP (1) EP0072352B1 (no)
KR (3) KR890003425B1 (no)
AR (3) AR240806A1 (no)
AT (1) ATE18397T1 (no)
AU (1) AU561395B2 (no)
CA (1) CA1196636A (no)
CY (1) CY1403A (no)
DD (1) DD202546A5 (no)
DE (1) DE3269625D1 (no)
DK (1) DK157881C (no)
ES (6) ES514856A0 (no)
FI (1) FI76074C (no)
GB (1) GB2103614B (no)
GR (1) GR77256B (no)
HK (1) HK93387A (no)
HU (1) HU189628B (no)
IE (1) IE53668B1 (no)
IL (1) IL66501A (no)
NL (1) NL930112I2 (no)
NO (1) NO161558C (no)
NZ (1) NZ201555A (no)
PT (1) PT75395B (no)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3242599A1 (de) * 1982-11-18 1984-05-24 Dr. Karl Thomae Gmbh, 7950 Biberach Neue benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel
US4473575A (en) * 1982-07-19 1984-09-25 Ciba-Geigy Corporation 3-Amino-(1)-benzazepin-2-one-1-alkanoic acids
EP0107095B1 (en) * 1982-09-30 1987-09-09 Merck & Co. Inc. 1-n-alkylcarboxy-benzofused lactams useful as antihypertensive agents
US4575503A (en) * 1983-02-10 1986-03-11 Ciba-Geigy Corporation 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids
US4564612A (en) * 1983-04-22 1986-01-14 Takeda Chemical Industries, Ltd. Condensed, seven-membered ring compounds and their use
US4539150A (en) * 1983-06-29 1985-09-03 Mitsui Toatsu Chemicals, Inc. Benzothiazepine derivatives and their methods of preparation
JPS608284A (ja) * 1983-06-29 1985-01-17 Mitsui Toatsu Chem Inc ベンゾチアゼピン誘導体およびその製造法
IL72523A (en) * 1983-08-12 1988-06-30 Takeda Chemical Industries Ltd 3-amino-4-oxo-2,3,4,5-tetrahydro-1,5-benzoxazepine derivatives,their production and pharmaceutical compositions containing them
US4638000A (en) * 1983-08-12 1987-01-20 Takeda Chemical Industries, Ltd. Condensed seven-membered ring compounds, their production and use
AU570710B2 (en) * 1983-08-12 1988-03-24 Takeda Chemical Industries Ltd. 4-oxo-2, 3, 4, 5-tetrahydro-1, 5-benzoxazepine derivatives
EP0166357A3 (en) * 1984-06-26 1988-10-26 Merck & Co. Inc. Benzofused lactams and pharmaceutical compositions containing them
CA1266647A (en) * 1984-06-26 1990-03-13 William H. Parsons Benzofused lactams useful as antihypertensive agents and as cholecystokinin antagonists
DE3586445T2 (de) * 1984-06-26 1993-01-14 Merck & Co Inc Kondensierte benzo-laktam-verbindungen und deren pharmazeutische zusammensetzungen.
US4785089A (en) * 1985-06-13 1988-11-15 Ciba-Geigy Corporation Novel sulfonic acid esters and their preparation
DE3704661A1 (de) * 1987-02-14 1988-08-25 Hoechst Ag Annelierte azepinon- und azocinon-derivate, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung, sowie zwischenprodukte bei ihrer herstellung
EP0322779A3 (en) * 1987-12-29 1991-05-08 Yoshitomi Pharmaceutical Industries, Ltd. Benzolactam compounds and pharmaceutical uses thereof
TW197945B (no) * 1990-11-27 1993-01-11 Hoechst Ag
GB9100028D0 (en) * 1991-01-02 1991-02-20 Ici Plc Compounds
GB9212308D0 (en) * 1992-06-10 1992-07-22 Ici Plc Therapeutic compositions
US5504080A (en) * 1992-10-28 1996-04-02 Bristol-Myers Squibb Co. Benzo-fused lactams
HUT72330A (en) * 1992-12-11 1996-04-29 Ciba Geigy Ag Substituted benzoxazepinone derivatives, process for producing them and pharmaceutical compositions containing them
GB9310075D0 (en) * 1993-05-17 1993-06-30 Fujisawa Pharmaceutical Co New mercapto-amide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
GB9311948D0 (en) * 1993-06-10 1993-07-28 Zeneca Ltd Substituted nitrogen heterocycles
US5801168A (en) * 1994-06-09 1998-09-01 Zeneca Limited Substituted nitrogen heterocycles
US5597922A (en) * 1994-07-29 1997-01-28 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Glycine receptor antagonist pharmacophore
EP1229913A4 (en) * 1999-11-18 2005-01-19 Antexpharma Inc SUBSTITUTED 1-BENZAZEPINE AND THEIR DERIVATIVES
EP2256104A1 (en) 2000-12-27 2010-12-01 Merck Patent GmbH Process for the preparation of alpha-aminosubstituted carboxylic acid amides
JP2004526735A (ja) 2001-03-27 2004-09-02 ランバクシー ラボラトリーズ リミテッド ベナゼプリルの製造方法
US6984645B2 (en) 2001-11-16 2006-01-10 Bristol-Myers Squibb Company Dual inhibitors of adipocyte fatty acid binding protein and keratinocyte fatty acid binding protein
EP1525189A1 (en) * 2002-07-26 2005-04-27 Ciba Specialty Chemicals Holding Inc. Crystalline polymorphic and amorphous forms of benazepril hydrochloride
KR100710548B1 (ko) * 2002-12-26 2007-04-24 에스케이 주식회사 (ｓ)-3-아미노-2,3,4,5-테트라히드로-2-옥소-1Ｈ-1-벤자제핀-1-아세트산 및 이의 에스테르 화합물의 제조방법
US7459474B2 (en) 2003-06-11 2008-12-02 Bristol-Myers Squibb Company Modulators of the glucocorticoid receptor and method
US8080579B2 (en) 2005-10-03 2011-12-20 The Regents Of The University Of Michigan Compositions and methods for treatment of inflammatory bowel disease
US7592461B2 (en) 2005-12-21 2009-09-22 Bristol-Myers Squibb Company Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
WO2008057862A2 (en) 2006-11-01 2008-05-15 Bristol-Myers Squibb Company MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-ϰB ACTIVITY AND USE THEREOF
EP2099767A1 (en) 2006-11-01 2009-09-16 Brystol-Myers Squibb Company Modulators of glucocorticoid receptor, ap-1, and/or nf- b activity and use thereof
WO2008151257A2 (en) 2007-06-04 2008-12-11 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US7828840B2 (en) 2007-11-15 2010-11-09 Med Institute, Inc. Medical devices and methods for local delivery of angiotensin II type 2 receptor antagonists
AU2009256157B2 (en) 2008-06-04 2014-12-18 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2009158380A1 (en) 2008-06-24 2009-12-30 Bristol-Myers Squibb Company Cyclopentathiophene modulators of the glucocorticoid receptor, ap-1, and/or nf-kappa b activity and use thereof
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
WO2014151206A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
AU2014235209B2 (en) 2013-03-15 2018-06-14 Bausch Health Ireland Limited Guanylate cyclase receptor agonists combined with other drugs
WO2014197720A2 (en) 2013-06-05 2014-12-11 Synergy Pharmaceuticals, Inc. Ultra-pure agonists of guanylate cyclase c, method of making and using same
WO2015027021A1 (en) 2013-08-22 2015-02-26 Bristol-Myers Squibb Company Imide and acylurea derivatives as modulators of the glucocorticoid receptor
CN113292495B (zh) * 2021-06-18 2022-09-13 迪嘉药业集团有限公司 一种 (s)-氨基化合物的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3395150A (en) * 1965-02-26 1968-07-30 Squibb & Sons Inc Benzothiazepine carboxamides and derivatives thereof
GB1305278A (no) * 1970-03-12 1973-01-31

Also Published As

Publication number Publication date
NO822722L (no) 1983-02-14
HK93387A (en) 1987-12-18
ES530658A0 (es) 1985-12-01
AR240806A1 (es) 1991-02-28
DD202546A5 (de) 1983-09-21
AR240806A2 (es) 1991-02-28
AR240807A1 (es) 1991-02-28
KR900001190B1 (ko) 1990-02-28
GB2103614B (en) 1984-11-21
IE53668B1 (en) 1989-01-04
ES526888A0 (es) 1985-04-16
DK157881B (da) 1990-02-26
ES8502974A1 (es) 1985-02-01
KR900001191B1 (ko) 1990-02-28
KR840001139A (ko) 1984-03-28
ES8602682A1 (es) 1985-12-01
CA1196636A (en) 1985-11-12
EP0072352B1 (de) 1986-03-05
FI822770L (fi) 1983-02-12
IE821929L (en) 1983-02-11
CY1403A (en) 1987-12-18
PT75395A (en) 1982-09-01
ES526886A0 (es) 1985-11-01
AU8701482A (en) 1983-05-12
NL930112I2 (nl) 1996-11-01
AR240807A2 (es) 1991-02-28
GB2103614A (en) 1983-02-23
KR890003425B1 (ko) 1989-09-20
FI76074C (fi) 1988-09-09
DK358682A (da) 1983-02-12
ES8606285A1 (es) 1986-04-16
GR77256B (no) 1984-09-11
DK157881C (da) 1990-07-23
ATE18397T1 (de) 1986-03-15
NO161558B (no) 1989-05-22
FI822770A0 (fi) 1982-08-09
ES526889A0 (es) 1986-02-01
NL930112I1 (nl) 1993-10-18
ES8601142A1 (es) 1985-11-01
IL66501A (en) 1987-10-20
NZ201555A (en) 1986-06-11
EP0072352A1 (de) 1983-02-16
AU561395B2 (en) 1987-05-07
DE3269625D1 (en) 1986-04-10
AR241222A1 (es) 1992-02-28
IL66501A0 (en) 1982-12-31
ES514856A0 (es) 1985-02-01
ES8604523A1 (es) 1986-02-01
PT75395B (en) 1985-11-15
FI76074B (fi) 1988-05-31
ES8504728A1 (es) 1985-04-16
HU189628B (en) 1986-07-28
ES526887A0 (es) 1986-04-16

Similar Documents

Publication Publication Date Title
NO161558C (no) Analogifremgangsmaate til fremstilling av antihypertensivebenzazepin-2-oner.
NO164712C (no) Analogifremgangsmaate til fremstilling av metylendifosfonsyre-derivater.
NO821586L (no) Fremgangsmaate til fremstilling av 1,2-diamino-cyklobuten-3,4-dioner.
NO821087L (no) Fremgangsmaate for fremstilling av cyklobutan-derivater.
NO158461C (no) Analogifremgangsmaate for fremstilling av fenyl-piperidin-propanol-derivater.
DK149949C (da) Analogifremgangsmaade til fremstilling af n-aryl-piperazinalkanamider
NO852907L (no) Fremgangsmaate til fremstilling av polyvinylklorid.
NO152904C (no) Analogifremgangsmaate til fremstilling av farmakologisk virksomme heksapyranoseforbindelser.
DK528982A (da) Fremgangsmaade til fremstilling af 13,14-didehydro-prostaglandiner
NO160263C (no) Analogifremgangsmaate til fremstilling av antibiotisk acetylerytromycistearat.
NO157861C (no) Analogifremgangsmaate til fremstilling av aminopyridaziner.
NO158136C (no) Fremgangsmaate til fremstilling av tiadiazolderivater.
NO155693C (no) Fremgangsmaate for fremstilling av eburnamoninderivater.
NO822634L (no) Fremgangsmaate for fremstilling av cefemderivater.
NO823183L (no) Fremgangsmaate til fremstilling av 1,2-dikloretan.
NO853066L (no) Fremgansmaate til fremstilling av 3-karbonyl-1-aminoalkyl-1h-indoler.
NO156865C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolderivater.
NO845071L (no) Fremgangsmaate til fremstilling av ferromangan.
NO823884L (no) Fremgangsmaate til fremstilling av 1,2-dikloretan
NO161064C (no) Analogifremgangsmaate til fremstilling av fenyl-nonatetraensyrederivater.
DK113483D0 (da) Fremgangsmade til fremstilling af 3,4-diphenyl-5-methylpyrazolderivater
NO157329C (no) Analogifremgangsmaate for fremstilling av 5-fluor pgi-forbindelser.
NO167290C (no) Analogifremgangsmaate for fremstilling av rifamycinderivater.
NO157736C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolderivater.
NO158736C (no) Analogifremgangsmaate for fremstilling av tetrahydropyridinderivater.

Legal Events

Date Code Title Description
MK1K Patent expired

Free format text: EXPIRED IN AUGUST 2002